Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 20, 2025Open Access

Detecting EGFR Gene Mutations on a Nanobioarray Chip

View Full Paper
Ask AI
Bookmark
Share

Authors

FXFang XuMBMontek BoparaiCOChristopher Oberc

Discussion

Loading...

Member takes

Overview

Point mutations in the EGFR gene impact lung cancer therapy, indicating gold nanoparticles enhance detection sensitivity.

Key Points

  • This research aims to detect specific point mutations in the EGFR gene related to lung cancer treatment.
  • Point mutations in EGFR were identified using a nanobioarray chip.
  • Probes were designed for detecting mutations in genomic samples through DNA hybridization.
  • Gold nanoparticles were used to enhance differentiation of sequences related to drug sensitivity.
  • Identified mutations include T790M (TKI-resistant) and L858R, L861Q (TKI-sensitive).
  • Gold nanoparticle-assisted method improved detection accuracy of mutated versus wild-type sequences.

Cite This Study

Xu et al. (2025) studied this question.

synapsesocial.com/papers/6945e9325151ab1219e4d60fhttps://doi.org/10.20944/preprints202512.1447.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Microdroplet Digital Polymerase Chain Reaction for Precision Detection of Non-Small Cell Lung Cancer Mutations2025
  2. 2Coupling enzymatic digestion with nanopore sensing for low-abundance EGFR-L858R mutation detection2025
  3. 3Detection of EGFR mutations at pM concentration in ten minutes using a microfluidic concentration and separation module2025
  4. 4From missed mutations to liquid clues: a new era of EGFR diagnostics in NSCLC2025
  5. 5Preferential Sensitivity of the <i>EGFR</i> L858M/L861R Mutation to Second-Generation EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer2025 · 2 citations